Ophthalmology Doctors in Easton, MD Accepting Medicare

5 Ophthalmology doctors found. Showing 1 - 5

Paul K. Dyer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4 Caulk Ln, Suite A, Easton, MD 21601 Phone: 410-822-7931

Joselito San Antonio Navaleza, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8420 Ocean Gtwy, Easton, MD 21601 Phone: 410-822-0424    Fax: 410-822-2283

Dr. Derrick Wade Shindler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8420 Ocean Gtwy, Easton, MD 21601 Phone: 410-822-0424    Fax: 410-822-2283

Alden James, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4 Caulk Ln, Suite A, Easton, MD 21601 Phone: 410-822-7931    Fax: 410-822-3523

Dr. Zuleika M Ghodsi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 405 Marvel Ct, Easton, MD 21601 Phone: 410-822-9801    Fax: 410-822-9805

News Archive

New drug Aliskiren shows promise for heart failure patients

A study published in the International Journal of Molecular Sciences, as part of a special issue "Heart Failure: From Molecular Basis to Therapy", in August 2019, shows that aliskiren, a drug approved by the US Food and Drug Administration (FDA), can improve survival for over 5 years, on average, and enhance life quality in patients who have been correctly diagnosed with heart failure.

Air pollution associated with cardiopulmonary mortality, morbidity: Researchers

Breathing polluted air increases stress on the heart's regulation capacity, up to six hours after inhalation of combustion-related small particles called PM2.5, according to Penn State College of Medicine researchers.

Older people appear better able than younger people to pick their battles

Older people are less likely than younger people to react aggressively when problems come up in their relationships, University of Michigan research shows.

Agile Therapeutics completes $45 million Series B Preferred Stock financing round

Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.

Wake Pharma to present clinical evidence in the treatment of wounds using Wound-Be-Gone at SAWC

Wake Pharma US announced today that clinical evidence in the treatment of wounds using Wound-Be-Gone® will be presented at the fall Society for Advance Wound Care Conference. The SAWC is being held in Washington, DC from September 16-18, 2009. The clinical evidence and data will be presented through posters on display during the meeting.

Read more Medical News

› Verified 1 days ago